Methods and apparatus are provided for removing emboli during an angioplasty, stenting or surgical procedure comprising a catheter having a funnel-shaped occlusion balloon of uniform thickness disposed on a distal end of the catheter. The occlusion balloon is fused to the distal end so that it provides a substantially seamless flow transition into a working lumen of the catheter. Additionally, a distal edge of the occlusion balloon is configured to be in close proximity with an inner wall of a vessel to facilitate blood flow into the catheter and efficiently remove emboli.

Patent
   6960222
Priority
Mar 13 1998
Filed
Jun 27 2002
Issued
Nov 01 2005
Expiry
May 13 2018
Assg.orig
Entity
Large
83
18
EXPIRED
1. Apparatus for removing emboli from a vessel during an interventional procedure, the apparatus comprising:
a catheter having proximal and distal ends, a working lumen extending therethrough; to define an interior surface, and an exterior surface; and
an occlusion balloon having a distal end affixed to the exterior surface of the catheter adjacent the distal end of the catheter and a proximal end everted to surround, and affixed to, the exterior surface of the catheter at a location proximal of the distal end of the catheter, the occlusion balloon having a contracted state suitable for insertion into a vessel and a deployed state configured to occlude antegrade flow in the vessel, the occlusion balloon having a substantially rhomboidal shape in the deployed state,
wherein the occlusion balloon consists of a single sheet of elastomeric having a substantially uniform wall thickness, and in the deployed state, provides a funnel-shaped surface that extends beyond the distal end of the catheter, a portion of the distal end of the occlusion element also affixed to the interior surface of the catheter to provide a seamless transition into the working lumen.
14. Apparatus for removing emboli from a vessel during an interventional procedure, the apparatus comprising:
a catheter having proximal and distal ends, a working lumen extending therethrough, the catheter comprising an interior polymer cover defining the working lumen, an exterior polymer cover, and a wire braid disposed between the interior polymer cover and the exterior polymer cover;
a radiopaque marker band disposed at the distal end of the catheter between the wire braid and the exterior polymer cover; and
an occlusion balloon having a distal end affixed to the exterior polymer cover and a proximal end everted to surround, and affixed to the exterior polymer cover at a location proximal of the distal end of the catheter, the occlusion balloon having a contracted state suitable for insertion into a vessel and a deployed state configured to occlude antegrade flow in the vessel,
wherein the occlusion balloon comprises an elastomeric material having a substantially uniform wall thickness, and in the deployed state, provides a funnel-shaped surface, the distal end of the occlusion balloon also affixed to the interior polymer cover to form a seamless transition into the working lumen.
2. The apparatus of claim 1 wherein the working lumen has an interior polymer cover.
3. The apparatus of claim 2 wherein the distal end of the occlusion balloon is fused to the interior polymer cover.
4. The apparatus of claim 3 wherein the distal end of the occlusion balloon is adhesively bonded to the interior polymer cover.
5. The apparatus of claim 1 wherein of the occlusion element is disposed in close proximity to the vessel wall in the deployed state.
6. The apparatus of claim 1 wherein an exterior surface of the catheter comprises an exterior polymer cover.
7. The apparatus of claim 6 wherein the proximal end of the occlusion balloon is fused to the exterior polymer cover.
8. The apparatus of claim 6 wherein the proximal end of the occlusion balloon is adhesively bonded to the exterior polymer cover.
9. The apparatus of claim 6 further comprising an inflation lumen disposed within the exterior polymer cover that is in fluid communication with the occlusion balloon.
10. The apparatus of claim 1 wherein the proximal end of the occlusion balloon is affixed to the exterior surface at a distance between about 10-20 mm proximal of the distal end of the catheter.
11. The apparatus of claim 1 further comprising a radiopaque marker band disposed at the distal end of the catheter.
12. The apparatus of claim 11 wherein the catheter comprises a wire braid disposed between the interior polymer cover and the exterior polymer cover, the apparatus further comprising a radiopaque marker band disposed between the wire braid and exterior polymer cover.
13. The apparatus of claim 1 further comprising a blood outlet port coupled to the proximal end of the catheter.
15. The apparatus of claim 14 wherein the distal end of the occlusion balloon is fused to the interior polymer cover.
16. The apparatus of claim 14 wherein the distalmost edge of the occlusion balloon is adhesively bonded to the interior polymer cover.
17.The apparatus of claim 14 wherein a distalmost edge of the occlusion element is disposed in close proximity to the vessel wall in the deployed state.
18. The apparatus of claim 17 wherein the distalmost edge of the occlusion element extends beyond the distal end of the catheter.
19. The apparatus of claim 14 wherein the proximal end of the occlusion balloon is fused to the exterior polymer cover.
20. The apparatus of claim 14 wherein the proximal end of the occlusion balloon is affixed to the exterior polymer cover at a distance between about 10-20 mm proximal of the distal end of the catheter.
21. The apparatus of claim 14 wherein the proximal end of the occlusion balloon is adhesively bonded to the exterior polymer cover.
22. The apparatus of claim 14 further comprising an inflation lumen disposed within the exterior polymer cover that is in fluid communication with the occlusion balloon.
23. The apparatus of claim 14 wherein the occlusion balloon further comprises a proximal taper and has a substantially rhomboidal shape in the deployed state.
24. The apparatus of claim 1 further comprising a blood outlet port coupled to the proximal end of the catheter.

The present application is a continuation-in-part of U.S. patent application Ser. No. 09/418,727, filed Oct. 15, 1999, now U.S. Pat. No. 6,423,032, which is a continuation-in-part of U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, now U.S. Pat. No. 6,206,868, which is a continuation-in-part of International Application PCT/US99/05469, filed Mar. 12, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 09/078,263, filed May 13, 1998, now U.S. Pat. No. 6,413,235.

This invention relates to apparatus and methods for removing emboli during vascular interventions. More particularly, the apparatus and methods of the present invention provide a catheter having an occlusion balloon of uniform thickness that facilitates retrograde flow and removes emboli from a treatment vessel via a funnel-shaped taper of the occlusion balloon.

Today there is a growing need to provide controlled access and vessel management during such procedures as stenting, atherectomy and angioplasty. Generally during these procedures there is a high opportunity for the release of embolic material. The emboli may travel downstream from the occlusion, lodging deep within the vascular bed and causing ischemia. The resulting ischemia may pose a serious threat to the health or life of a patient if the blockage forms in a critical area, such as the heart, lungs, or brain.

Several previously known apparatus and methods attempt to remove emboli formed during endovascular procedures by aspirating the emboli out of the vessel of interest using a catheter having an occlusion balloon. These previously known occlusion balloons, however, have various drawbacks, including variability in deployment of the balloon to the desired shape, inefficiency in removing emboli, and/or high cost and complicated processes associated with manufacturing the balloon.

In applicant's co-pending U.S. patent application Ser. No. 09/418,727, filed Oct. 15, 1999, which is incorporated herein by reference in its entirety, applicant describes the use of a bell or pear-shaped occlusion balloon disposed on the distal end of an arterial catheter. The occlusion balloon comprises a compliant material having a variable thickness along its length to provide a bell-shape when inflated. The balloon is affixed to distal end of the catheter so that a distal portion of the balloon extends beyond the distal end of the catheter to provide an atraumatic tip or bumper for the catheter.

The balloon of that catheter may be formed using previously known techniques, such as varying the thickness of the balloon wall to achieve the preferred bell-shape in the deployed position. Such processes, however, can lead to variability in the final product due to the manufacturing process. Because variable thickness balloons present greater difficulties during manufacture than balloons having uniform wall thickness, the cost of such balloons may be higher.

In view of the foregoing limitations of previously known devices, it would be desirable to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to enhance manufacturability of the occlusion balloon.

It also would be desirable to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to reduce manufacturing cost and enhance product yield.

It further would be desirable to provide an apparatus for removing emboli from a vessel comprising a catheter having an occlusion balloon of uniform thickness that facilitates retrograde flow and efficiently removes emboli.

In view of the foregoing, it is an object of this invention to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to enhance manufacturability of the occlusion balloon.

It also is an object of the present invention to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to reduce manufacturing cost and enhance product yield.

It further is an object of the present invention to provide an apparatus for removing emboli from a vessel comprising a catheter having an occlusion balloon of uniform thickness that facilitates retrograde flow and efficiently removes emboli.

The foregoing objects of the present invention are accomplished by providing interventional apparatus comprising a catheter having proximal and distal ends, a working lumen extending therethrough and an occlusion balloon having proximal and distal ends disposed on the distal end of the catheter. The occlusion balloon has a contracted state suitable for insertion into a vessel and a deployed state configured to occlude antegrade flow in the vessel.

In a preferred embodiment, the catheter comprises an inner layer covered with a layer of flat stainless steel wire braid and a polymer cover. A distal section of the occlusion balloon is melt-bonded to a distalmost end of the inner layer and, optionally, to a distalmost end of the polymer cover to form a substantially seamless transition into the working lumen of the catheter. The proximal end of the occlusion balloon is everted and affixed to the polymer cover to form an inflation chamber between the polymer cover and the balloon.

In the deployed state, the occlusion balloon is configured to extend distal of the catheter and provides a funnel-shaped transition into the working lumen of the catheter. A distal edge of the occlusion balloon is configured to be in close proximity with an inner wall of a vessel to facilitate retrograde flow into the working lumen of the catheter and efficiently remove emboli. Additionally, because the occlusion balloon of the present invention comprises a uniform thickness, the balloon may be more reliable, easier to manufacture and more cost-effective than an occlusion balloon having a variable thickness along its length.

Preferred methods of making and using the apparatus of the present invention also are disclosed.

Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:

FIGS. 1A-1B are, respectively, side and sectional views of a previously known occlusion balloon in contracted and deployed states;

FIGS. 2A-2B are, respectively, a schematic view of apparatus in accordance with the present invention and a cross-sectional view along line A—A of FIG. 2A;

FIGS. 3A-3B are side sectional views illustrating a preferred configuration of the distal end of the catheter of FIG. 2;

FIGS. 4A-4B are side sectional views of the occlusion balloon of the present invention in contracted and deployed states, respectively; and

FIG. 5 is a schematic view of apparatus of the present invention being used during an interventional procedure.

Referring to FIGS. 1A-1B, a bell-shaped occlusion balloon, as described in applicant's commonly assigned allowed U.S. patent application Ser. No. 09/418,727, filed May 8, 2001, which is incorporated herein by reference, is described. Occlusion balloon 20 is shown in contracted and deployed states in FIGS. 1A and 1B, respectively. Balloon 20 is affixed to distal end 26 of catheter 22, for example, by gluing or a melt-bond, so that opening 27 in balloon 20 leads into lumen 28 of catheter 22. Balloon 20 preferably is wrapped and heat treated during manufacture so that distal portion 29 of the balloon extends beyond the distal end of catheter 22 and provides an atraumatic tip or bumper for the catheter. In accordance with manufacturing techniques which are known in the art, occlusion balloon 20 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated.

As described hereinabove, the variable thickness characteristic of occlusion balloon 20, which is used to deploy the balloon to the preferred bell-shape, presents certain manufacturing challenges. In particular, manufacturing a balloon having a variable wall thickness can lead to reduced yield due to variability of the manufacturing process. Additionally, a variable thickness balloon may be difficult to manufacture and may have a higher cost relative to a balloon having a uniform thickness.

Referring now to FIG. 2, a first embodiment of apparatus constructed in accordance with principles of the present invention is described. Apparatus 40 comprises catheter 41 having proximal and distal ends and working lumen 58 extending therethrough. Catheter 41 comprises occlusion balloon 42 having proximal and distal ends affixed to the distal end of catheter 41, and preferably comprises radiopaque marker band 65 disposed at the distal end of catheter 41 to facilitate positioning of the distal end of the catheter.

Occlusion balloon 42 comprises a uniform thickness material having a contracted state suitable for insertion into a vessel and a deployed state in which occlusion balloon 42 occludes antegrade flow in the vessel. In the deployed state, occlusion balloon 42 comprises distal taper 66 that is configured to provide a funnel-shaped transition into working lumen 58 so that blood flows in a non-turbulent fashion from a treated vessel into catheter 41. Additionally, distal edge 68 is configured to be in close proximity with an inner wall of a vessel to facilitate blood flow into catheter 41 and efficiently remove emboli.

Catheter 41 preferably comprises inner layer 60 of low-friction polymeric material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainless steel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX), as shown in FIG. 2B. Working lumen 58 is defined as a lumen within an interior surface of inner layer 60. Inflation lumen 63 preferably is disposed within polymer cover 62 so that the inflation lumen does not substantially increase the overall profile of catheter 41.

Apparatus 40 preferably further includes proximal hemostatic port 43, e.g., a Touhy-Borst connector, inflation port 44, and blood outlet port 48. Inflation port 44 is coupled to inflation lumen 63, which in turn is coupled to occlusion balloon 42. Proximal hemostatic port 43 and working lumen 58 of catheter 41 are sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the working lumen when a guidewire (not shown) is positioned within the working lumen.

Blood outlet port 48, which is in fluid communication with working lumen 58, may be coupled to an external aspiration device, e.g., a syringe, to cause blood flow distal of occlusion balloon 42 to flow into working lumen 58. Alternatively, in a preferred embodiment, blood outlet port 48 may be coupled to a venous return catheter to form an arterial-venous shunt suitable for providing retrograde flow in a treatment vessel. This aspiration embodiment comprising an arterial-venous shunt is described in detail in applicant's commonly-assigned, above-incorporated U.S. patent application Ser. No. 09/418,727.

Referring now to FIG. 3, a preferred configuration of catheter 41 and a preferred method for affixing occlusion balloon 42 to the distal end of catheter 41 are described. In FIG. 3A, the distal end of catheter 41 is shown from a side sectional view as comprising inner layer 60 covered with a layer of flat stainless steel wire braid 61 and polymer cover 62. Radiopaque marker band 65 preferably is disposed at the distal end of catheter 41 between wire braid 61 and polymer cover 62, as shown in FIG. 3A. In accordance with principles of the present invention, occlusion balloon 42 comprises a uniform thickness along its length, as illustrated in FIGS. 3A-3B.

In a preferred method of manufacture, distal end 50 of occlusion balloon 42 is positioned atop polymer cover 62 near the distal end of catheter 41 and just distal of opening 70 of polymer cover 62, as shown in FIG. 3A. Distal end 50 of occlusion balloon 42 then is affixed to polymer cover 62, preferably using a melt-bond or, alternatively, using a biocompatible glue. At this time, proximal end 52 of occlusion balloon 42 extends freely beyond the distal end of catheter 41, as shown in FIG. 3A. For purposes of clarifying terminology used herein, although proximal end 52 of occlusion balloon 42 appears situated distal of distal end 50 in FIG. 3A, this is because proximal end 52 will subsequently be everted to extend proximal of distal end 50, as described hereinbelow.

In a next manufacturing step, distal section 51 of occlusion balloon 42, which is situated just proximal of distal end 50, is melt-bonded to at least one polymeric layer of catheter 41. Specifically, in a preferred embodiment, distal section 51 of occlusion balloon 42 is melt-bonded to distalmost end 85 of inner layer 60 and, optionally, to distalmost end 87 of polymer cover 62 to form fusion joint 67, as shown in FIG. 3A. The melt-bonding of the plurality of polymeric materials at fusion joint 67 provides substantially seamless transition 72 between occlusion balloon 42 and inner layer 60. Additionally, because fusion joint 67 is formed from a plurality of compliant polymeric materials, fusion joint 67 is capable of achieving a flexible range of motion.

Proximal end 52 of occlusion balloon 42 then is everted so that it extends proximally and radially outward from catheter 41, as shown in FIGS. 3B and 4A. Proximal end 52 is affixed to polymer cover 62, preferably using a melt-bond or, alternatively, using a biocompatible glue, at a distance between about 10-20 mm proximal of the distal end of catheter 41, as shown in FIG. 4A. This creates inflation chamber 74 between polymer cover 62 and an interior surface of balloon 42. Opening 70, which is disposed in a lateral surface of polymer cover 62, is in fluid communication with inflation lumen 63 and inflation chamber 74, as shown in FIG. 3B. Proximal end 52 of occlusion balloon 42 may be stretched while it being affixed to polymer cover 62 so that apparatus 40 may achieve a reduced profile in the contracted state.

The fusion of occlusion balloon 42 to catheter 41 at fusion joint 67 and subsequent eversion of the balloon creates substantially seamless transition 72 into working lumen 58, as shown in FIG. 3B. In accordance with principles of the present invention, the provision of substantially seamless transition 72 may help reduce flow impedance into working lumen 58 and enhance flow within a treated vessel.

Referring now to FIGS. 4A-4B, deployment of apparatus 40 within vessel V of a patient is described. In FIG. 4A, occlusion balloon 42 is shown in a contracted state suitable for percutaneous and transluminal insertion into a patient's vessel. Occlusion balloon 42 is inflated via inflation port 44, inflation lumen 63 and opening 70, and deploys to a predetermined configuration having proximal taper 64 and distal taper 66, as shown in FIG. 4B. The predetermined configuration may be determined, for example, using a pre-molding process in accordance with manufacturing techniques that are known in the art. In the deployed state, an outer surface of central section 75, which is formed between proximal and distal tapers 64 and 66, is substantially flush with an inner wall of vessel V. As will be understood by those skilled in the art, the expanded diameter of central section 75 may be sized accordingly for different vessels.

Distal edge 68 is defined as a section of occlusion balloon 42 that is formed between central section 75 and distal taper 66. In the deployed state, distal edge 68 is configured to be in close proximity with an inner wall of vessel V to facilitate blood flow into working lumen 58 and efficiently remove emboli.

Distal taper 66 provides a funnel-shaped flow transition from distal edge 68 into working lumen 58. Additionally, as described hereinabove, fusion joint 67 provides substantially seamless transition 72 from occlusion balloon 42 into working lumen 58 due to the melt-bond between balloon 42 and inner layer 60 of catheter 41.

Referring now to FIG. 5, a preferred method for using apparatus 40 of FIG. 2A during an interventional procedure, such as balloon angioplasty, is described. In a first step, guidewire 83 is inserted into a patient's vasculature and a distal end of guidewire 83 is disposed just proximal of stenosis S, which is located in vessel V. A dilator (not shown) that is disposed within catheter 41 then is inserted over guidewire 83 to advance catheter 41 to a desired position proximal of stenosis S. When catheter 41 is properly positioned, e.g., as determined under fluoroscopy using radiopaque marker band 65, the dilator may be removed. Occlusion balloon 42 then is inflated via inflation port 44 of FIG. 2A, preferably using a radiopaque contrast solution, to occlude antegrade flow in vessel V. Aspiration is provided through working lumen 58 of catheter 41 to cause retrograde flow to occur in vessel V distal of occlusion balloon 42, as illustrated by the arrows in FIG. 5.

Aspiration may be provided through working lumen 58 via blood outlet port 48 using an external aspiration device, e.g., a syringe, or alternatively using a venous return catheter to form an arterial-venous shunt, as described hereinabove.

An interventional instrument, such as conventional angioplasty balloon catheter 80 having balloon 82, may be loaded through hemostatic port 43 and working lumen 58 and positioned within stenosis S, preferably via guidewire 83. Hemostatic port 43 is closed and the angioplasty balloon is actuated to disrupt stenosis S. As seen in FIG. 5, emboli E formed during the interventional procedure are directed into working lumen 58 via the retrograde flow established.

Occlusion balloon 42 provides a substantially uniform funnel-shaped transition from an inner wall of vessel V into working lumen 58 of catheter 41. Distal edge 68, which is configured to be in close proximity with an inner wall of vessel V, facilitates flow into working lumen 58 and efficiently removes emboli. Additionally, the funnel-shaped transition provided by distal taper 66 and substantially seamless transition 72 into the working lumen via fusion joint 67 improves retrograde flow dynamics into working lumen 58.

Advantageously, because the present invention utilizes an occlusion balloon having a uniform thickness and relies on pre-molding of the occlusion balloon to obtain the desired deployed shape, a variable thickness occlusion balloon is not required. As noted hereinabove, use of an occlusion balloon having a uniform thickness provides several advantages, including enhanced manufacture, reduced cost and increased reliability.

While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.

Betelia, Rainier, Vo, Hung Van

Patent Priority Assignee Title
10004531, Nov 20 2012 INARI MEDICAL, INC Methods and apparatus for treating embolism
10045790, Sep 24 2012 INARI MEDICAL, INC Device and method for treating vascular occlusion
10085765, Aug 08 2008 Incept, Inc. Apparatus and methods for accessing and removing material from body lumens
10098651, Jan 10 2017 INARI MEDICAL, INC Devices and methods for treating vascular occlusion
10238406, Oct 21 2013 INARI MEDICAL, INC Methods and apparatus for treating embolism
10335186, Nov 20 2012 INARI MEDICAL, INC Methods and apparatus for treating embolism
10342571, Oct 23 2015 INARI MEDICAL, INC Intravascular treatment of vascular occlusion and associated devices, systems, and methods
10349960, Jun 09 2014 INARI MEDICAL, INC Retraction and aspiration device for treating embolism and associated systems and methods
10524811, Oct 23 2015 INARI MEDICAL, INC Intravascular treatment of vascular occlusion and associated devices, systems, and methods
10588655, Nov 20 2012 INARI MEDICAL, INC Methods and apparatus for treating embolism
10668254, Aug 25 2014 Radius Medical LLC Stabilizing and sealing catheter for use with a guiding catheter
10709471, Nov 20 2012 INARI MEDICAL, INC Methods and apparatus for treating embolism
10744304, Aug 28 2009 Boston Scientific Medical Device Limited Inverted balloon neck on catheter
10849647, Aug 08 2008 Incept, Inc. Apparatus and methods for accessing and removing material from body lumens
10912577, Jan 10 2017 Inari Medical, Inc. Devices and methods for treating vascular occlusion
10926064, Jun 15 2012 W. L. Gore & Associates, Inc. Vascular occlusion and drug delivery devices, systems, and methods
11000682, Sep 06 2017 Inari Medical, Inc. Hemostasis valves and methods of use
11058445, Oct 21 2013 Inari Medical, Inc. Methods and apparatus for treating embolism
11058451, Oct 23 2015 Inari Medical, Inc. Intravascular treatment of vascular occlusion and associated devices, systems, and methods
11058848, May 02 2019 Covidien LP Catheter including expandable member
11147571, Nov 20 2012 Inari Medical, Inc. Device and method for treating vascular occlusion
11154314, Jan 26 2018 Inari Medical, Inc. Single insertion delivery system for treating embolism and associated systems and methods
11191556, Mar 01 2018 Covidien LP Catheter including an expandable member
11433218, Dec 18 2015 Inari Medical, Inc. Catheter shaft and associated devices, systems, and methods
11529158, Mar 25 2004 Inari Medical, Inc. Method for treating vascular occlusion
11547836, Aug 25 2014 Radius Medical LLC Stabilizing and sealing catheter for use with a guiding catheter
11554005, Aug 13 2018 INARI MEDICAL, INC System for treating embolism and associated devices and methods
11559382, Aug 13 2018 INARI MEDICAL, INC System for treating embolism and associated devices and methods
11589880, Dec 20 2007 AngioDynamics, Inc. System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure
11642209, Aug 13 2018 INARI MEDICAL, INC System for treating embolism and associated devices and methods
11648020, Feb 07 2020 AngioDynamics, Inc.; AngioDynamics, Inc Device and method for manual aspiration and removal of an undesirable material
11648028, Nov 20 2012 Inari Medical, Inc. Methods and apparatus for treating embolism
11690639, Mar 01 2018 Covidien LP Catheter including an expandable member
11697011, Sep 06 2017 Inari Medical, Inc. Hemostasis valves and methods of use
11697012, Sep 06 2017 Inari Medical, Inc. Hemostasis valves and methods of use
11730515, Apr 23 2010 Mark D. Wieczorek, PC Transseptal access device and method of use
11744691, Aug 13 2018 Inari Medical, Inc. System for treating embolism and associated devices and methods
11806033, Jan 10 2017 Inari Medical, Inc. Devices and methods for treating vascular occlusion
11832837, Mar 25 2004 INARI MEDICAL, INC Method for treating vascular occlusion
11832838, Mar 25 2004 Inari Medical, Inc. Method for treating vascular occlusion
11833023, Aug 13 2018 Inari Medical, Inc. System for treating embolism and associated devices and methods
11839393, Mar 25 2004 Inari Medical, Inc. Method for treating vascular occlusion
11844921, Sep 06 2017 Inari Medical, Inc. Hemostasis valves and methods of use
11849963, Jan 26 2018 Inari Medical, Inc. Single insertion delivery system for treating embolism and associated systems and methods
11864779, Oct 16 2019 Inari Medical, Inc. Systems, devices, and methods for treating vascular occlusions
11865276, Jun 15 2012 W. L. Gore & Associates, Inc. Vascular occlusion and drug delivery devices, systems, and methods
11865291, Sep 06 2017 Inari Medical, Inc. Hemostasis valves and methods of use
11890180, Aug 13 2018 Inari Medical, Inc. System for treating embolism and associated devices and methods
11896246, Dec 20 2007 AngioDynamics, Inc. Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter
7343875, Oct 24 2003 PATHWAY TECHNOLOGIES, LLC NEVADA Method and apparatus for creating a pathway in an animal
7647891, Oct 24 2003 Pathway Technologies, LLC Method and apparatus for creating a pathway in an animal
7654264, Jul 18 2006 Covidien LP Medical tube including an inflatable cuff having a notched collar
7959644, May 16 2008 Hemostatic guiding catheter
7971553, Apr 03 2002 Pathway Technologies, LLC Method and apparatus for creating a pathway in an animal
8075510, Dec 20 2007 AngioDynamics, Inc Systems and methods for removing undesirable material within a circulatory system
8096299, Jul 18 2006 Covidien LP Medical tube including an inflatable cuff having a notched collar
8109985, Jul 23 2008 Boston Scientific Scimed, Inc Occlusion crossing device and method
8136483, Oct 24 2003 Pathway Technologies, LLC Method and apparatus for creating a pathway in an animal
8206347, Jun 06 2005 C. R. Bard, Inc. Feeding device including balloon tip and method of manufacture
8257382, Mar 29 2007 Boston Scientific Medical Device Limited Lumen reentry devices and methods
8257383, Mar 29 2007 Boston Scientific Medical Device Limited Lumen reentry devices and methods
8506512, Dec 20 2007 AngioDynamics, Inc Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter
8551043, Apr 21 2006 C R BARD, INC Feeding device and bolster apparatus and method for making the same
8613717, Dec 20 2007 AngioDynamics, Inc Systems and methods for removing and fragmenting undesirable material within a circulatory system
8702744, May 09 2005 NEXEON MEDSYSTEMS, INC Apparatus and methods for renal stenting
8715244, Jul 07 2009 C R BARD, INC Extensible internal bolster for a medical device
8721675, Mar 29 2007 Boston Scientific Medical Device Limited Lumen reentry devices and methods
8734374, Dec 20 2007 AngioDynamics, Inc Systems and methods for removing undesirable material within a circulatory system during a surgical procedure
8858533, Jun 29 2004 C R BARD, INC Methods and systems for providing fluid communication with a gastrostomy tube
9126015, Aug 08 2008 INCEPT, INC Apparatus and methods for accessing and removing material from body lumens
9381326, Jun 15 2012 W L GORE & ASSOCIATES, INC Vascular occlusion and drug delivery devices, systems, and methods
9427557, Jul 23 2008 Boston Scientific Scimed, Inc. Occlusion crossing device and method
9555215, May 05 2010 Cook Medical Technologies LLC Treatment fluid delivery method, and turbulator for promoting uptake of a treatment agent
9572751, Jul 07 2009 C. R. Bard, Inc. Extensible internal bolster for a medical device
9682224, Jun 29 2004 C. R. Bard, Inc. Method and systems for providing fluid communication with a gastrostomy tube
9700332, Oct 23 2015 INARI MEDICAL, INC Intravascular treatment of vascular occlusion and associated devices, systems, and methods
9844387, Oct 23 2015 INARI MEDICAL, INC Intravascular treatment of vascular occlusion and associated devices, systems, and methods
9878132, Jun 15 2012 W L GORE & ASSOCIATES, INC Vascular occlusion and drug delivery devices, systems, and methods
D744639, Aug 06 2008 AngioDynamics, Inc. Cannula tip
D916280, Oct 17 2016 AngioDynamics, Inc. Reinforcement arms and collar for a cannula tip
D916281, Oct 17 2016 AngioDynamics, Inc. Reinforcement arms and collar for a cannula tip
D931447, Oct 17 2016 AngioDynamics, Inc. Reinforcement arms and collar for a cannula tip
D972723, Mar 17 2021 AngioDynamics, Inc.; AngioDynamics, Inc Reinforcement arms and collar for an expandable cannula tip
Patent Priority Assignee Title
3831587,
4571240, Aug 12 1983 Advanced Cardiovascular Systems, Inc.; ADVANCED CARDIOVASCULAR SYSTEMS INC , A CA CORP Catheter having encapsulated tip marker
4575371, Apr 16 1981 ESTATE OF PERCY NORDQVIST Urinary catheter
4781681, Sep 15 1987 GV Medical, Inc. Inflatable tip for laser catheterization
4794928, Jun 10 1987 Angioplasty device and method of using the same
4820270, Oct 08 1982 Balloon catheter and process for the manufacture thereof
4921478, Feb 23 1988 SAUNDERS, MYLES L , M D Cerebral balloon angioplasty system
5074845, Jul 18 1989 Advanced Cardiovascular Systems, INC Catheter with heat-fused balloon with waist
5102415, Sep 06 1989 Apparatus for removing blood clots from arteries and veins
5171305, Oct 17 1991 CREDIT SUISSE FIRST BOSTON MANAGEMENT CORPORATION Linear eversion catheter with reinforced inner body extension
5441485, Feb 24 1994 THINQ TANQ, INC Bladder catheter
5601581, May 19 1995 General Surgical Innovations, Inc Methods and devices for blood vessel harvesting
5833650, Jun 05 1995 KARDIAMETRICS, LLC Catheter apparatus and method for treating occluded vessels
5997503, Feb 12 1998 CITIBANK, N A Catheter with distally distending balloon
6221042, Sep 17 1999 Boston Scientific Scimed, Inc Balloon with reversed cones
6238412, Nov 12 1997 Genesis Technologies LLC Biological passageway occlusion removal
6264631, Feb 12 1998 CITIBANK, N A Catheter with distally distending balloon
6423032, Mar 13 1998 W L GORE & ASSOCIATES, INC Apparatus and methods for reducing embolization during treatment of carotid artery disease
/////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jun 27 2002Gore Enterprise Holdins, Inc.(assignment on the face of the patent)
Aug 16 2002VAN VO, HUNGARTERIA MEDICAL SCIENCE, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0133940216 pdf
Oct 09 2002BETELIA, RAINIERARTERIA MEDICAL SCIENCE, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0133940216 pdf
Nov 18 2004ARTERIA MEDICAL SCIENCE, INC Gore Enterprise Holdings, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0165260319 pdf
Jan 30 2012Gore Enterprise Holdings, IncW L GORE & ASSOCIATES, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0279060508 pdf
Date Maintenance Fee Events
May 01 2009M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
May 01 2013M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Jun 09 2017REM: Maintenance Fee Reminder Mailed.
Nov 27 2017EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Nov 01 20084 years fee payment window open
May 01 20096 months grace period start (w surcharge)
Nov 01 2009patent expiry (for year 4)
Nov 01 20112 years to revive unintentionally abandoned end. (for year 4)
Nov 01 20128 years fee payment window open
May 01 20136 months grace period start (w surcharge)
Nov 01 2013patent expiry (for year 8)
Nov 01 20152 years to revive unintentionally abandoned end. (for year 8)
Nov 01 201612 years fee payment window open
May 01 20176 months grace period start (w surcharge)
Nov 01 2017patent expiry (for year 12)
Nov 01 20192 years to revive unintentionally abandoned end. (for year 12)